An announcement from COSCIENS Biopharma ( (TSE:CSCI) ) is now available.
COSCIENS Biopharma Inc. has announced the acceptance of a management cease trade order (MCTO) by the Ontario Securities Commission due to a potential delay in filing its annual financial statements and related documents. The MCTO restricts trading by the company’s CEO and CFO but does not affect other shareholders. COSCIENS is working diligently to complete the filings by April 7, 2025, and will issue bi-weekly updates until the filings are complete. The delay will not impact the company’s stock listing on the Nasdaq Capital Market.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a life science company that develops and commercializes a diverse range of cosmeceutical, nutraceutical, and pharmaceutical products. The company focuses on leveraging proprietary extraction technology to produce active ingredients from renewable plant resources, which are used in popular skincare brands and are being developed for potential nutraceutical and pharmaceutical applications.
YTD Price Performance: 3.30%
Average Trading Volume: 25,857
Technical Sentiment Signal: Buy
Current Market Cap: $9.33M
See more data about CSCI stock on TipRanks’ Stock Analysis page.